Kinshasa, DRC — The Democratic Republic of Congo is dealing with the country’s largest Ebola outbreak, fueled by the rapid spread of the Bundibugyo virus.
As of August 16, 2026, the epidemic has claimed over 4,900 lives, with a fatality rate of 46. 86%.
The World Health Organization (WHO) has deemed this a Public Health Emergency of International Concern due to the absence of a vaccine or specific treatment for the Bundibugyo virus.
The outbreak, which originated in Ituri Province on May 14, 2026, presents unprecedented challenges for health authorities. Dr. Mohamed Janabi, WHO Regional Director for Africa, has emphasized the difficulty in reaching patients early in the outbreak, calling for improved transport systems for patient care.
The Bundibugyo virus, known for its rapid progression and high mortality rate, has been exacerbated by remote and densely populated areas, insecurity, and high population and trade movements.
The lack of a vaccine or specific treatment adds to the complexity of response efforts. There is, however, a glimmer of hope as the world’s first vaccine against the Bundibugyo ebolavirus enters phase 1 human trials.
The WHO and Congolese authorities are collaborating to strengthen surveillance, contact tracing, clinical preparedness, and community engagement, though reaching patients in time for effective treatment remains a significant challenge. Local transport associations have highlighted shortcomings in the patient transport system, which may contribute to delays in treatment. Calls for improved infrastructure and logistics have intensified, aiming to ensure that patients can be transported quickly and safely to treatment centers.
The international community remains vigilant, with the Centers for Disease Control and Prevention (CDC) and other global health organizations closely monitoring the outbreak.
The rapid spread of the Bundibugyo virus underscores the need for robust public health systems and international cooperation in the face of emerging infectious diseases.
The coming weeks will be crucial in determining the trajectory of this outbreak. With the vaccine trials underway, there is hope for a breakthrough, but the immediate challenge remains the urgent need for effective treatment and prevention strategies to save lives and contain the spread of the virus.
*Additional reporting by ImNews | Sources consulted: 5*
—
This original article was produced by the ImNews editorial team
Source: france24 – Africa
Source: FRANCE 24
